Information Update: In Vitro Fertilization Product (Endometrin) Recalled Due to Possible Problems with Effectiveness

(firmenpresse) - OTTAWA, ONTARIO -- (Marketwired) -- 11/22/13 -- Ferring Pharmaceuticals, in consultation with Health Canada, is voluntarily recalling two lots of Endometrin (100 mg progesterone tablet), a prescription medication used during in vitro fertilization. The lots (0804.209A-1 and 0804.219A-1) were released in July and September of 2013, according to the company.

The voluntary recall is a precautionary measure due to the potential damage of tablets from a packaging equipment malfunction that has caused brown discolouration of some tablets and/or blister packs. As a result, the company has informed Health Canada that the discoloured tablets could potentially be altered, which could affect the therapeutic effectiveness of the product and lead to early pregnancy loss.

According to the company, the problem has occurred with different lots in other countries but has not been seen with the lots in Canada to date.

Health Canada has not received any reports of adverse events as of November 15, 2013 associated with Endometrin. Ferring Pharmaceutical has also indicated that it has not received any reports of adverse events for this product.

Health Canada is monitoring the recall and will update Canadians should new information be identified.

Advice to patients:

Advice to healthcare professionals:

Stay connected with Health Canada and receive the latest advisories and product recalls using tools.

Egalement disponible en francais



Contacts:
Media Inquiries:
Health Canada
(613) 957-2983

Public Inquiries:
(613) 957-2991
1-866-225-0709

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: Marketwired
Datum: 22.11.2013 - 20:12 Uhr
Sprache: Deutsch
News-ID 319639
Anzahl Zeichen: 0

contact information:
Town:

OTTAWA, ONTARIO

Kategorie:

Government & Administration

Diese Pressemitteilung wurde bisher 244 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Information Update: In Vitro Fertilization Product (Endometrin) Recalled Due to Possible Problems with Effectiveness"
steht unter der journalistisch-redaktionellen Verantwortung von

Health Canada (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Media Advisory: Health Canada ...

OTTAWA, ONTARIO -- (Marketwired) -- 12/16/13 -- Parliamentary Secretary Eve Adams, on behalf of Rona Ambrose, Minister of Health, along with a toy safety expert from Health Canada`s Consumer Product Safety Division, will hold a demonstration on sma ...

Consumer Product Alert: Health Canada Urges Parents to Safeguard Children from C ...

OTTAWA, ONTARIO -- (Marketwired) -- 12/11/13 -- Issue:Health Canada is urging parents and caregivers to safeguard children against the strangulation hazard posed by products with cords. While exploring their natural environment, children can become ...

Use a Digital Food Thermometer for Safe Cooking ...

OTTAWA, ONTARIO -- (Marketwired) -- 12/10/13 -- The only reliable way to make sure that meat, poultry, fish and seafood dishes reach safe internal cooking temperatures before serving is to use a digital food thermometer.While we often look for other ...

Alle Meldungen von Health Canada